Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N. Urman
988 an Open-Label Phase 2 Clinical Trial of Topical Remetinostat Gel for Basal Cell Carcinoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Related publications
Topical Therapy for Superficial Basal Cell Carcinoma
International Journal of Clinical & Experimental Dermatology
Mocetinostat for Relapsed Classical Hodgkin's Lymphoma: An Open-Label, Single-Arm, Phase 2 Trial
The Lancet Oncology
Oncology
PCN141 Quality of Life in Small Cell Lung Cancer: Results of an Open-Label Phase III Clinical Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase I Open Label Liver-Directed Gene Therapy Clinical Trial for Acute Intermittent Porphyria
Journal of Hepatology
Hepatology
An Open-Label, Phase 2 Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Meglumine Antimoniate Intralesional Infiltration for Localised Cutaneous Leishmaniasis: A Single Arm, Open Label, Phase II Clinical Trial
Memorias do Instituto Oswaldo Cruz
Medicine
Microbiology
A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Ibrutinib as Initial Therapy for Elderly Patients With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma: An Open-Label, Multicentre, Phase 1b/2 Trial
The Lancet Oncology
Oncology
Selumetinib in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum: An Open-Label, Single-Arm, Phase 2 Study
The Lancet Oncology
Oncology
